Subjects Perceived as Embarrassing During a Consultation in General Medical Practice

General Practice Clinical Trial

— Gene-MG  

Official title:

Subjects Perceived as Embarrassing During a Consultation in General Medical Practice

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06130605
• Other study ID #: 2023_RIPH_006_Gene-MG
• Status: Not yet recruiting
• Start date: December 1, 2023
• Est. completion date: June 1, 2024

Study information

• Verified date: November 2023
• Source: Université de Reims Champagne-Ardenne
• Contact: Barbe Coralie, DR
• Phone: 0326913665
• Email: coralie.barbe[@]univ-reims.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Optimal medical care requires transparency and honesty. However, it is not always easy to address some issues that may be considered too personal, intimate or taboo, such as mental health, sexuality, addiction and death. Patients' approach to these issues may be influenced by the profile of their general practitioner, or by the atmosphere of the consultation.

This retention of information by the patient, whether voluntary or not, can lead to adverse events related to care due to a misunderstanding between doctor and patient.

Description:

The main objective is to describe the proportion of patients limiting the subjects addressed during a general medicine consultation by gene, modesty and/or fear of judgment The secondary objective is to study the factors associated with limitation of subjects addressed by patient by gene, modesty and/or fear of judgment during a general medicine consultation.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 2000
• Est. completion date: June 1, 2024
• Est. primary completion date: February 1, 2024
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Over 18 years of age

• Agreeing to take part in the study

Exclusion Criteria:

• Minors

• Protected by law (guardianship, curatorship, safeguard of justice)

• Refusing to take part in the study

Related Conditions & MeSH terms

• General Practice

Intervention

Other:
• Data collection
Data collection

Locations

Country	Name	City	State
France	Ufr Medecine Urca	Reims
France	Université de Reims Champagne Ardenne	Reims

Sponsors (1)

Lead Sponsor	Collaborator
Université de Reims Champagne-Ardenne

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	limitation of subjects addressed by gene, modesty and/or fear of judgment	Proportion of patients who have ever restricted the subjects discussed during a general medical consultation by gene, modesty and/or fear of judgment	Day 0